1 Sept 2026
Mutant isocitrate dehydrogenase in cancer: Structural biology, small-molecule inhibitors, and future drug discovery strategiesPublisher siteDrug Discovery Today, Colorectal Cancer Treatments and Studies
Active, last published 2026
In synthesis and biological activity
Anwar A
El-Hamaky
Scholar“Research focused on Synthesis and biological activity and adjacent fields.”
Tanta University
Egypt
Claim Your ProfileEgypt8
H-index
199
Citations
Anwar has not officially claimed their profile. If you are Anwar, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
nwar A El-Hamaky is a researcher working on Synthesis and biological activity. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Anwar's work has been cited 199 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Synthesis and biological activity×3Click Chemistry and Applications×2Histone Deacetylase Inhibitors Research×2Cancer therapeutics and mechanisms×2Cholinesterase and Neurodegenerative Diseases×2
04 · Where I am
Affiliations
Affiliation on published researchTanta University, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
9 works28 May 2026
Molecular Boomerangs Against Cancer: Design, Synthesis, Biological Evaluation, and In Silico Study of Novel Dual PARP‐1/EGFR InhibitorsPublisher siteDrug Development Research, PARP inhibition in cancer therapy
5 Mar 2026
Biphenyl urea derivatives as novel GPX4 inhibitors: ferroptosis-mediated antiproliferative activity against CNS cancer cellsPublisher siteBioorganic Chemistry, Ferroptosis and cancer prognosis
22 Jun 20255cites
Triazole-functionalized benzofuran and benzothiophene semicarbazides as novel VEGFR-2-targeted anti-cancer agentsPublisher siteBioorganic Chemistry, Click Chemistry and Applications
29 Apr 202513cites
Development of isatin-functionalized benzenesulfonamides as novel carbonic anhydrase II and VII inhibitors with antiepileptic potentialPublisher siteEuropean Journal of Medicinal Chemistry, Enzyme function and inhibition
21 Apr 202511cites
Novel benzofuran-conjugated indolin-2-ones as anticancer agents; design, synthesis, biological assessments, and molecular modeling insightsPublisher siteBioorganic Chemistry, Bioactive Compounds and Antitumor Agents
16 Apr 202516cites
Shooting an Arrow against Convulsion: Novel Triazole-Grafted Benzenesulfonamide Derivatives as Carbonic Anhydrase II and VII InhibitorsPublisher siteJournal of Medicinal Chemistry, Enzyme function and inhibition
25 Mar 20258cites
Discovery of 1-phenyl-1,2,3-triazole ureas as dual VEGFR-2/JNK-1 type II kinase inhibitors targeting pancreatic cancerPublisher siteInternational Journal of Biological Macromolecules, Cancer Mechanisms and Therapy
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Anwar?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you